FDAnews Device Daily Bulletin

JOHNSON & JOHNSON UNIT ORTHONEUTROGENA ACQUIRES ISRAEL BASED COLBAR LIFESCIENCE FOR UNDISCLOSED SUM

July 14, 2006
A A

Johnson & Johnson, a health care company, announced that on July 6, OrthoNeutrogena, a division of Ortho-McNeil Pharmaceutical, Inc., a Johnson & Johnson company, has purchased privately held biotechnology company Colbar LifeScience Ltd., specializing in reconstructive medicine and tissue engineering.
Trading Markets Live